FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michelle Elliott

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Ming Y Lim; Mark R Litzow; Animesh Pardanani; Mrinal S Patnaik; Ayalew Tefferi; Alexandra P Wolanskyj; Aref Al-Kali; Aneel A Ashrani; Kebede H Begna; Michelle A Elliott; Diane E Grill; William J Hogan; C Christopher Hook; Scott H Kaufmann; Louis Letendre; Rajiv K Pruthi
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.
Michelle A Elliott; William J Hogan; C Christopher Hook; Scott H Kaufmann; Louis Letendre; Animesh Pardanani; Rajiv K Pruthi; Ayalew Tefferi; alexandra wolanskyj; Aref Al-Kali; Aneel A Ashrani; Kebede H Begna; Mark R Litzow
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
Harris V K Naina; R K Pruthi; David J Inwards; David Dingli; Mark R Litzow; Stephen M Ansell; H J William; Angela Dispenzieri; Francis Buadi; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; Patrick B Johnston; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Shaji Kumar
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michelle Elliott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ming Y Lim; Mark R Litzow; Animesh Pardanani; Mrinal S Patnaik; Ayalew Tefferi; Alexandra P Wolanskyj; Aref Al-Kali; Aneel A Ashrani; Kebede H Begna; Michelle A Elliott; Diane E Grill; William J Hogan; C Christopher Hook; Scott H Kaufmann; Louis Letendre; Rajiv K Pruthi
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.
Leukemia & lymphoma 2013;54(6):1263-7.
2012: Michelle A Elliott; William J Hogan; C Christopher Hook; Scott H Kaufmann; Louis Letendre; Animesh Pardanani; Rajiv K Pruthi; Ayalew Tefferi; alexandra wolanskyj; Aref Al-Kali; Aneel A Ashrani; Kebede H Begna; Mark R Litzow
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
European journal of haematology 2012;88(3):237-43.
2011: Harris V K Naina; R K Pruthi; David J Inwards; David Dingli; Mark R Litzow; Stephen M Ansell; H J William; Angela Dispenzieri; Francis Buadi; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; Patrick B Johnston; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Shaji Kumar
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
Bone marrow transplantation 2011;46(2):291-3.
2010: Shernan G Holtan; William J Hogan; Michelle A Elliott; Stephen M Ansell; David J Inwards; Luis F Porrata; Patrick B Johnston; Ivana N M Micallef; Martha Q Lacy; Dennis A Gastineau; Mark R Litzow
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.
Bone marrow transplantation 2010;45(12):1699-703.
2010: Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Krista M Laumann; Jake Allred; Susan M Geyer; Mark R Litzow; Dennis A Gastineau; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; Patrick B Johnston; William J Hogan; Morie A Gertz
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
American journal of hematology 2010;85(6):409-13.
2010: Mark R Litzow; Prema P Peethambaram; Stephanie L Safgren; Gary L Keeney; Stephen M Ansell; Angela Dispenzieri; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; W L Lingle; Lynn C Hartmann; M H Frost; B A Barrette; Harry J Long; Vera J Suman; Joel M Reid; Matthew M Ames; S H Kaufmann
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
Bone marrow transplantation 2010;45(3):490-7.
2010: Ayalew Tefferi; Terra L Lasho; Mrinal M Patnaik; Christy M Finke; K Hussein; William J Hogan; Michelle A Elliott; Mark R Litzow; Curtis A Hanson; Animesh Pardanani
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.
Leukemia 2010;24(1):105-9.
2009: Michelle A Elliott; John A Heit; Rajiv K Pruthi; Dennis A Gastineau; Jeffrey L Winters; C Christopher Hook
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.
European journal of haematology 2009;83(4):365-72.
2009: Harris V K Naina; Morie A Gertz; Michelle A Elliott
Thrombotic microangiopathy during peripheral blood stem cell mobilization.
Journal of clinical apheresis 2009;24(6):259-61.
2008: Morie A Gertz; Stephen M Ansell; David Dingli; Angela Dispenzieri; Francis K Buadi; Michelle A Elliott; Dennis A Gastineau; Suzanne R Hayman; William J Hogan; David J Inwards; Patrick B Johnston; Shaji Kumar; Martha Q Lacy; Nelson Leung; Ivana N M Micallef; Luis F Porrata; Barbara A Schafer; Robert C Wolf; Mark R Litzow
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1131-8.
2008: Luciano J Costa; Vilmarie Rodriguez; Luis F Porrata; Martha Q Lacy; Michelle A Elliott; Morie A Gertz; Dennis A Gastineau; Mark R Litzow
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Bone marrow transplantation 2008;42(7):497-8.
2008: Pankaj Malhotra; William J Hogan; Mark R Litzow; Michelle A Elliott; Dennis A Gastineau; Stephen M Ansell; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Ayalew Tefferi
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
Leukemia & lymphoma 2008;49(9):1724-30.
2008: Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Mark R Litzow; Dennis A Gastineau; David J Inwards; Michelle A Elliott; Ivana N M Micallef; Stephen M Ansell; William J Hogan; Luis F Porrata; Patrick A Johnston; Bekele Afessa; Alan Bryce; Robert A Kyle; Morie A Gertz
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
2007: Michelle A Elliott; Mark R Litzow; Louis Letendre; Robert C Wolf; Curtis A Hanson; Ayalew Tefferi; Martin S Tallman
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.
Blood 2007;110(13):4172-4.
2007: Michelle A Elliott; S Verstovsek; David Dingli; S M Schwager; Ruben A Mesa; C Y Li; Ayalew Tefferi
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
Leukemia research 2007;31(11):1503-9.
2006: Animesh Pardanani; Ross Levine; Terra L Lasho; Yana Pikman; Ruben A Mesa; Martha Wadleigh; David P Steensma; Michelle A Elliott; alexandra wolanskyj; William J Hogan; Rebecca F McClure; Mark R Litzow; D Gary Gilliland; Ayalew Tefferi
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.
Blood 2006;108(10):3472-6.
2006: Animesh Pardanani; Rhett P Ketterling; Chin-Yang Li; Mrinal M Patnaik; alexandra wolanskyj; Michelle A Elliott; John K Camoriano; Joseph H Butterfield; Gordon W Dewald; Ayalew Tefferi
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
Leukemia research 2006;30(8):965-70.
2006: Michelle A Elliott; Ayalew Tefferi; William J Hogan; Louis Letendre; Dennis A Gastineau; Stephen M Ansell; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Mark R Litzow
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia.
Bone marrow transplantation 2006;37(11):1003-8.
2006: Angela Dispenzieri; Martha Q Lacy; Jerry A Katzmann; S Vincent Rajkumar; Roshini S Abraham; Suzanne R Hayman; Shaji Kumar; Raynell Clark; Robert A Kyle; Mark R Litzow; David J Inwards; Stephen M Ansell; Ivana M Micallef; Luis F Porrata; Michelle A Elliott; Patrick B Johnston; Philip R Greipp; Thomas E Witzig; Steven R Zeldenrust; stephen russell; Dennis A Gastineau; Morie A Gertz
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
2006: Michelle A Elliott
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined.
Best practice & research. Clinical haematology 2006;19(3):571-93.
2005: Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Mark R Litzow; Peter M Anderson; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; S M Ansell; Luis F Porrata; Michelle A Elliott; John A Lust; Philip R Greipp; S Vincent Rajkumar; R Fonseca; Thomas E Witzig; C Erlichman; J A Sloan; Morie A Gertz
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Leukemia 2005;19(1):118-25.
2004: Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; S M Ansell; Michelle A Elliott; Dennis A Gastineau; David J Inwards; Ivana N M Micallef; Luis F Porrata; Ayalew Tefferi; Mark R Litzow
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
Bone marrow transplantation 2004;34(12):1025-31.
2004: Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Joseph P McConnell; Mark R Litzow; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; William J Hogan; S Vincent Rajkumar; Rafael Fonseca; Philip R Greipp; Thomas E Witzig; John A Lust; Steven R Zeldenrust; Denise S Snow; Suzanne R Hayman; Christopher G A McGregor; Allan S Jaffe
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
2004: Michelle A Elliott; Robert C Wolf; Christopher C Hook; Rajiv K Pruthi; John A Heit; Louis Letendre; Ayalew Tefferi; Scott H Kaufmann; Ruben A Mesa; Mark R Litzow
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin.
Leukemia & lymphoma 2004;45(8):1545-9.
2004: Ruben A Mesa; Michelle A Elliott; Georgene Schroeder; Ayalew Tefferi
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):883-9.
2004: Ayalew Tefferi; Michelle A Elliott
Schistocytes on the peripheral blood smear.
Mayo Clinic proceedings. Mayo Clinic 2004;79(6):809.
2004: Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; Terry M Therneau; Dirk R Larson; Matthew F Plevak; S Vincent Rajkumar; Rafael Fonseca; Philip R Greipp; Thomas E Witzig; John A Lust; Steven R Zeldenrust; Denise S Snow; Suzanne R Hayman; Mark R Litzow; Dennis A Gastineau; Ayalew Tefferi; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; Morie A Gertz
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
2004: Michelle A Elliott
Chronic neutrophilic leukemia: a contemporary review.
Current hematology reports 2004;3(3):210-7.
2003: Michelle A Elliott; William L Nichols; Elizabeth A Plumhoff; Stephen M Ansell; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ivana N M Micallef; Ayalew Tefferi; Mark R Litzow
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):421-30.
2002: Ayalew Tefferi; Ruben A Mesa; Leigh A Gray; David P Steensma; John K Camoriano; Michelle A Elliott; Animesh Pardanani; Stephen M Ansell; Timothy G Call; Gerardo Colon-Otero; Georgene Schroeder; Curtis A Hanson; Gordon W Dewald; Scott H Kaufmann
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Blood 2002;99(10):3854-6.
2002: Michelle A Elliott; Ruben A Mesa; Chin-Yang Li; C Christopher Hook; Stephen M Ansell; Ralph M Levitt; Susan M Geyer; Ayalew Tefferi
Thalidomide treatment in myelofibrosis with myeloid metaplasia.
British journal of haematology 2002;117(2):288-96.
2002: Michelle A Elliott; Louis Letendre; Curtis A Hanson; Ayalew Tefferi; Gordon W Dewald
The prognostic significance of trisomy 8 in patients with acute myeloid leukemia.
Leukemia & lymphoma 2002;43(3):583-6.
2001: Ruben A Mesa; Ayalew Tefferi; Michelle A Elliott; H Clark Hoagland; Timothy G Call; Georgene Schroeder; Soo-Young Yoon; Chin-Yang Li; Leigh A Gray; S Margolin; C Christopher Hook
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.
British journal of haematology 2001;114(1):111-3.
2001: Ayalew Tefferi; Michelle A Elliott; David P Steensma; C Christopher Hook; A Dispenzieria; Curtis A Hanson; Georgene Schroeder; Louis Letendre
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome.
Leukemia research 2001;25(2):183-5.
2001: Michelle A Elliott; Gordon W Dewald; Ayalew Tefferi; Curtis A Hanson
Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study.
Leukemia 2001;15(1):35-40.
2000: Ruben A Mesa; Michelle A Elliott; Ayalew Tefferi
Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Blood reviews 2000;14(3):121-9.
2000: Ayalew Tefferi; Michelle A Elliott; P C Kao; S Yoon; Ihab El-Hemaidi; Thomas C Pearson
Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
Blood 2000;96(4):1582-4.
2000: Robert D McBane; Michelle A Elliott; J G White; J E Charlesworth; M G Costopoulos; Whyte G Owen; William L Nichols
Fechtner syndrome: physiologic analysis of macrothrombocytopenia.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(3):243-7.
1999: Michelle A Elliott; Ayalew Tefferi
Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
Blood reviews 1999;13(3):163-70.
1999: Michelle A Elliott; Louis Letendre; Chin-Yang Li; James D Hoyer; Julie E Hammack
Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine.
British journal of haematology 1999;104(4):689-94.
1998: Michelle A Elliott; Michael G Chen; MN Silverstein; Ayalew Tefferi
Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
British journal of haematology 1998;103(2):505-11.
1997: Michelle A Elliott; Ayalew Tefferi; W F Marshall; Martha Q Lacy
Disseminated nocardiosis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;20(5):425-6.
1997: Ayalew Tefferi; Michelle A Elliott; Lawrence Solberg; MN Silverstein
New drugs in essential thrombocythemia and polycythemia vera.
Blood reviews 1997;11(1):1-7.
1997: Michelle A Elliott; Ayalew Tefferi
Interferon-alpha therapy in polycythemia vera and essential thrombocythemia.
Seminars in thrombosis and hemostasis 1997;23(5):463-72.